Cancer immunotherapy .net

Prof. Den Otter

cancerimmunotherapy@yahoo.com

Information for doctors Information for patients Information on our research group I want to support this research

Information for doctors Information voor patienten Informatie over onze onderzoeksgroep Ik wil dit onderzoek steunen

Promotor of the following theses

1. H.F.J. Dullens. Cellular immunotherapy of murine tumours. 1975. 2. H. van Loveren. Macrofagen en lymfocyten in cellulaire afweer tegen tumoren. 1981. 3. E. Pels. Specific Macrophage Arming Factor. 1982. 4. R.A. de Weger. Lymphocyte induced macrophage cytotoxicity. 1982. 5. W.H. de Jong. Immunotherapy of cancer with Bacillus Calmette Guerin. BCG potency testing and BCG induced tumor immunity. 1985. 6. W.R. Klein. BCG immunotherapy in bovine ocular squamous cell carcino-ma and equine sarcoid. 1986. 7. O. Huber-Bruning. Of human cartilage. The induction of proteoglycan-loss in human articular cartilage explants of different ages. 1987. 8. D.J. der Kinderen. A new concept of oncogenesis with an evaluation in retinoblastoma. 1987. 9. H.J. Haisma. Monoclonal antibodies and cancer. Studies on the use of monoclonal antibodies for imaging and therapy of cancer, with special emphasis on ovarian carcinoma. 1987. 10. E.A. Runhaar. Tumour cell killing by human monocytes. 1989. 11. M.M. Denyn. Expression of the calcitonin gene family. A hybridohistochemical study. 1991. 12. P.A. Steerenberg. Bacillus Calmette-Guérin (BCG): Immunopotentiation and tumor immunity at the site of the tumor. 1991. 13. B. Wilbrink. Cartilage destruction: Antigen-specific T cell activation and cytokines. 1991. 14. R.J. Vandebriel. Initiation of the cellular immune response against murine tumor allografts. 1991. 15. H.A. Maas. Immunotherapy of cancer with low-dose interleukin-2. 1991. 16. Th.E. Merchant. Characterization of human breast disease using phosphorus magnetic resonance spectroscopy and proton magnetic resonance imaging. 1992. 17. V.P.M.G. Rutten. Immunotherapy of bovine ocular squamous cell carcinoma. 1992. 18. J.J. Bergers. Liposomes as a carrier system for protein. Studies on the mode of protein incorporation and their potential as tumor vac-cins. 1992. 19. J. Voshol. The role of cell surface glycoconjugates in the recognition of target cells by human natural killer cells and by lymphokine-activated killer cells. 1993. 20. M.R. Bernsen. Local chemo-immunotherapy with low doses of cisplatin and recombinant interleukin-2 in three murine tumor models. 1993. 21. E.T.M. Balemans. PEG-IL-2: An effective drug in local immunotherapy of a guinea pig carcinoma. 1993. 22. L.T.M. van der Ven. Role of Insulin-like growth factors (IGFs) in regulation of growth and transformation of mammalian cells. 1995. 23. A.C. Moll. Epidemiological aspects of retinoblastoma in The Netherlands. 1996. 24. M.R.L. Krul. Towards an experimental vaccine against Human Papillomaviruses. 1996. 25. J.W. Koten. Het 4-mutatiemodel voor carcinogenese. 1998. 26. L.A. Everse. Preclinical indications in support of combined-modality treatment of cancer using radiotherapy and interleukin-2. 1998. 27. R. van den Ham. A molecular study refining the understanding of spermatogenic stem cell development. Gonocytes: what’s in the name? 2000. 28. J. Cadée. Biocompatible dextran hydrogels for the controlled release of interleukin-2 in cancer immunotherapy. 2001. 29. A. Masztalerz. Anticancer therapy with interleukin-2 and interleukin-12 . 2003. 30. T.J. Moore. Manipulation of germ cells from neonatal rat testis. 2004. 31. K.A. Slot. Hormonal regulation of apoptosis in the ovary under normal physiological and pathological conditions. 2005. Current Ph.D. students: 32. R. Stewart 33. E.V. Moiseeva 34. P.G.P.M. Ziekman 35. C. Eiermann 36. J. Tan.

List of publications

Information for doctors (alleen in het engels) Information for patients Informatie voor patienten Information about our research group Informatie over onze onderzoeksgroep I want to support this research Ik wil dit onderzoek steunen